RCT: Inhibition of Prekallikrein for hereditary angioedema.
23 Mar, 2022 | 10:02h | UTCInhibition of Prekallikrein for Hereditary Angioedema – New England Journal of Medicine (link to abstract – $ for full-text)
Related:
Phase 2 RCT: Prophylactic use of garadacimab in patients with hereditary angioedema.
Evaluation and Management of Angioedema in the Emergency Department